Health Claims and FTC Advertising Law
|
|
- Bryan Potter
- 5 years ago
- Views:
Transcription
1 Health Claims and FTC Advertising Law Institute of Medicine Food Forum Workshop The Human Microbiome, Diet, and Health Michelle Rusk, Attorney* Division of Advertising Practices *Staff presentation does not necessarily represent views of FTC or any Commissioner. February 23, 2012
2 Overview Coordination with FDA FTC advertising law basics What constitutes adequate substantiation for health claims Recent case examples
3 FTC/FDA Coordination FTC authority overlaps with FDA for foods, supplements, drugs, other health and medical products Two agencies coordinate closely Liaison Agreement FDA Primary authority over labeling FTC Primaryauthority authority over advertising (except Rx drugs)
4 FTC/FDA Coordination FTC legal framework differs from FDA: Primarily a law enforcement agency No pre market approval of claims No regulatory distinction between product categories (drug, supplement, food) No regulatory distinction between types of claims li (health, disease, structure/function) t ti
5 FTC Advertising Law FTC Act, Sections 5 and 12 Advertising must be truthful and not misleading. Objective claims must be substantiated before they are made. All advertising investigations begin with two basic questions
6 1. What claims are conveyed?
7 2. Are the claims substantiated?
8 FTC Substantiation Policy General Doctrine: TheFTC typically requires claims about the efficacy or safety of dietary supplements to be supported with competent and reliable scientific evidence, defined as tests, analyses, research, studies or other evidence based on the expertise of professionals in the relevant area, conducted and evaluated in an objective manner by persons qualified to do so, using procedures generally accepted in the profession to yield accurate and reliable results. (Sec II.B)
9 FTC Substantiation Policy In other words: Rigorous but flexible approach (look to experts in the field) No fixed formula for number, length, size of studies (quality over quantity) Generally expect double blind placebo controlled controlled human clinicals FDA substantiation guidance for supplements closely mirrors FTC substantiation policy
10 FTC Substantiation Policy Internal Validity of Studies Control and blinding Duration (does effect persist?) Dose/response relationship Recognized biological mechanism Peer review/publication in reputable journal is a plus Statistically significant AND clinically meaningful
11 FTC Substantiation Policy Context Don t evaluate studies in isolation Consider all relevant evidence Reconcile inconsistent/conflicting results Claim i may need to be qualified Don t make claim if weight of evidence contradicts t
12 FTC Substantiation Policy
13 FTC Substantiation Policy Relevance to Product/Claim: Product and claims should match the science Amount/form of ingredient Population studied Degree/nature of effect Strength of the science
14 Recent Actions The Dannon Company, Inc. (Consent 2009)
15 Recent Actions Danactive children s dairy drink helps prevent colds and flu ( L. CaseiImmunitatas ) t Activia yogurt relieves irregularity ( Bifidus Regularis ) Results in test group were not statistically significant ifi compared to placebo group; 8 out of 10 studies on Activia showed no significant effect The Dannon Company, Inc. (Consent 2009)
16 Recent Actions Nestlé Healthcare Nutrition (consent 2010)
17 Recent Actions Probiotic straw and drink for children Claims: prevention of upper respiratory tract infections; protects against cold and flu; reduces absence from school; reduces duration of acute diarrhea in children up to 13 Some good evidence but claims went beyond science Nestlé Healthcare Nutrition (Consent 2010)
18 Final Thoughts New FTC order language more concrete and specific about the science required to substantiate claims Not more burdensome; just more transparent Order may require prior FDA approval under a drug monograph or pursuant to NLEA for disease prevention/risk reduction Order may specify two studies, on the product or essentially equivalent product, conducted by different and independent researchers New language applies ONLY to the claims and products covered by the order.
19 More guidance at business.ftc.gov
The opinions expressed are the speaker s and not his company s.
May 13, 2010 James Brooks, Ph.D. Vice President, Science & Technology Christine Burdick-Bell, J.D. Vice President, Legal & Regulatory Affairs Pharmavite LLC The opinions expressed are the speaker s and
More informationFDA Regulation of Claims on Dietary Supplement and Food Products
FDA Regulation of Claims on Dietary Supplement and Food Products Patricia Kaeding August 2004 Topics FDA Overview What are claims Why claims matter Categories of claims Regulatory requirements for types
More informationTranslating the science into efficacy claims on probiotic or prebiotic products in the US market
Translating the science into efficacy claims on probiotic or prebiotic products in the US market American Dairy Science Association Annual Meeting July 13, 2010 Dairy & Food Culture Technologies Consulting
More informationIs POM Wonderful Really Wonderful? How the FTC, the FDA and Private Litigation Address Deceptive Food Advertising
Is POM Wonderful Really Wonderful? How the FTC, the FDA and Private Litigation Address Deceptive Food Advertising Dee Pridgen October 9, 2014 14 th Consumer Issues Conference Pom Wonderful achieve immortality?
More informationAdvertising: The Federal Trade Commission and Private Rights of Action Venable LLP
Advertising: The Federal Trade Commission and Private Rights of Action 2012 Venable LLP 1 Agenda FTC s Role and Authority Claim Substantiation Private Rights of Action 2 FTC s Role and Authority FTC Authority
More informationEnforcement Policy Statement on Marketing Claims for OTC Homeopathic Drugs
This document is scheduled to be published in the Federal Register on 12/13/2016 and available online at https://federalregister.gov/d/2016-29770, and on FDsys.gov [BILLING CODE: 6750-01S] FEDERAL TRADE
More informationWhat Regulators and Other Attorneys Will Not Tell You About FDA, FTC, and Class Action Lawsuits Venable LLP
What Regulators and Other Attorneys Will Not Tell You About FDA, FTC, and Class Action Lawsuits 2012 Venable LLP 1 Agenda Current Enforcement Trends What is a Claim? Substantiation Hot Topic Claims FDA
More informationGive Me a Break, Is That Really a Disease Claim?
Give Me a Break, Is That Really a Disease Claim? Najla Guthrie, President/CEO KGK Synergize Todd A. Harrison Partner Venable LLP Claudia A. Lewis, Partner Venable LLP ENGREDEA 2014 March 7, 2014 2012 Venable
More informationSubstantiation of Health Claims in Advertising. Richard L. Cleland Division of Advertising Practices Federal Trade Commission
Substantiation of Health Claims in Advertising Richard L. Cleland Division of Advertising Practices Federal Trade Commission The FTC Act prohibits: Background unfair or deceptive acts or practices in or
More informationThe science and regulations of probiotic food and supplement product labeling
Ann. N.Y. Acad. Sci. ISSN 0077-8923 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES Issue: Probiotic Foods and Supplements The science and regulations of probiotic food and supplement product labeling Mary
More informationDecember 4, 2017 VIA ELECTRONIC SUBMISSION
VIA ELECTRONIC SUBMISSION December 4, 2017 Dockets Management Staff (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: Development of a List of pre-dietary Supplement
More informationClaims That Can Get You in Trouble
Claims That Can Get You in Trouble What s New in Advertising Claims for Dietary Supplements Steve Mister President & CEO, CRN FTC Requirements for Advertising Claims must be truthful, not misleading and
More informationNEUROSCIENCE TRIALS OF THE FUTURE: A WORKSHOP Pragmatic Trials: Challenges and Opportunities for Neuroscience Trials
NEUROSCIENCE TRIALS OF THE FUTURE: A WORKSHOP Pragmatic Trials: Challenges and Opportunities for Neuroscience Trials Mark J. Cziraky, PharmD, CLS Vice President of Research HealthCore Inc. Wilmington,
More informationGetting Your Ingredient to Market: Understanding Your Regulatory Options Venable LLP
Getting Your Ingredient to Market: Understanding Your Regulatory Options 2013 Venable LLP 1 Overview of the Governing Laws 1. The Federal Food, Drug, and Cosmetic Act ("FD&C Act"): Requires foods, cosmetics,
More information2:00pm - 3:00pm: Breakout 3 - Case Discussions Technician Option: Functional Foods
2:00pm - 3:00pm: Breakout 3 - Case Discussions Technician Option: Functional Foods ACPE UAN 107-000-11-017-L01-T Activity Type: Knowledge-Based 0.1 CEU/1.0 Hr Program Objectives for Technicians: Upon completion
More informationII. History and importance of defining Healthy : Government/regulatory science perspective
II. History and importance of defining Healthy : Government/regulatory science perspective Barbara Schneeman, Ph.D. Professor Emerita of Nutrition University of California, Davis Main Question What are
More informationGUIDELINES FOR USE OF NUTRITION AND HEALTH CLAIMS
1 CAC/GL 23-1997 GUIDELINES FOR USE OF NUTRITION AND HEALTH CLAIMS CAC/GL 23-1997 Nutrition claims should be consistent with national nutrition policy and support that policy. Only nutrition claims that
More informationGyan Rai, PhD 06/04/2015
* Gyan Rai, PhD 06/04/2015 Objectives: 2 1. Current Definition of Probiotics 2. Regulatory Categorization & Intended Uses 3. Probiotics & Medical Foods- How to Fit? 4. Regulatory Implications & Considerations
More informationUS Whole Grain Regulatory & Policy Framework
US Whole Grain Regulatory & Policy Framework International Forum for Whole Grain Foods Development Hosted by: PNDC, Whole Grains Council & Grains for Health Foundation Kathy Wiemer MS, RD Fellow/Director
More informationUnderstanding probiotics and health
Understanding probiotics and health Gemma Laws MSc Student Microbiology and Immunology Department The gut microbiota The name given to the total microbial population living in our intestine Bacteria, fungi,
More informationRe: Docket No. FDA D Presenting Risk Information in Prescription Drug and Medical Device Promotion
1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org August 25, 2009 Dockets Management Branch (HFA-305) Food and Drug Administration 5600 Fishers Lane, Rm. 1061 Rockville,
More informationPhase 2b/3 Topline Trial Results
Phase 2b/3 Topline Trial Results RP-G28 For the Treatment of Lactose Intolerance March 2017 Forward - Looking Statement To the extent that statements contained in this presentation are not descriptions
More informationU.S. FDA Perspective on Food Supplements/TM
U.S. FDA Perspective on Food Supplements/TM IKHLAS A. KHAN National Center for Natural Products Research, Department of Pharmacognosy and Research Institute of Pharmaceutical Sciences, School of Pharmacy,
More informationFood Labeling Enforcement and Compliance Priorities in the Current Environment
Food Labeling Enforcement and Compliance Priorities in the Current Environment Veronica Colas, Senior Associate April 12, 2018 Role of FDA Regulations and Guidance in Class Action Litigation Why Class
More informationThe Tobacco Control Act s Premarket Review Authorities: Reports on Substantial Equivalence and Exemption Requests (905(j))
The Tobacco Control Act s Premarket Review Authorities: Reports on Substantial Equivalence and Exemption Requests (905(j)) January 12, 2011 Cristi Stark, MS Senior Regulatory Health Project Manager Office
More informationOverview Consumer Health Products Law and Compliance Issues
Overview Consumer Health Products Law and Compliance Issues The First Asia Pacific Pharmaceutical Compliance Congress September 2011 CHONG JIN NG Assistant General Counsel Asia Shared Legal Services Consumer
More informationProblems with the 1906 Act
Problems with the 1906 Act failed to provide clear-cut meanings and specific means for enforcement insufficient funding for enforcement USDA was responsible for testing, but no standards for foods were
More informationPaul M. Coates, Ph.D.
Dietary Supplements in the United States: Claims and Evidence The National Institute of Health and Nutrition December 2008 Paul M. Coates, Ph.D. Office of Dietary Supplements National Institutes of Health
More informationFDA s Evidence-Based Review System
Food & Drug January 28, 2009 FDA Releases Final Guidance for Evidence-Based Review System for the Scientific Evaluation of Health Claims On January 16, 2009, the Food and Drug Administration (FDA) announced
More informationA NATURAL EXPERIMENT: CLAIMS, Consumers, and CASES. Neal Hooker, Christopher Simons, Efthimios Parasidis. Efthimios Parasidis
A NATURAL EXPERIMENT: CLAIMS, Consumers, and CASES Neal Hooker, Christopher Simons, Efthimios Parasidis The Ohio State University Efthimios Parasidis Associate Professor of Law and Public Health The Ohio
More informationUnderstanding Today s Probiotics Regulations in South East Asia. Wai Mun Poon Regulatory Affairs Consultant
Understanding Today s Probiotics Regulations in South East Asia Wai Mun Poon Regulatory Affairs Consultant waimun@wongsjasia.com Probiotic Foods in South East Asia More probiotic foods are being introduced
More informationFood Labeling: Policy Rationale IFT Food Policy Impact, 2011
Food Labeling: Policy Rationale IFT Food Policy Impact, 2011 Barbara O. Schneeman, Ph.D. Office of Nutrition, Labeling and Dietary Supplements CFSAN-FDA General Labeling Provisions FDA s authority to regulate
More informationHomeopathy: the need for robust evidence to inform consumer choice
Homeopathy: the need for robust evidence to inform consumer choice Opening and Introduction: Dame Anne Glover and Thierry Courvoisier Homeopathy and the EU: Robin Fears Homeopathy in Sweden: Dan Larhammar
More informationFDLI ANNUAL CONFERENCE May 4, 2018
FDLI ANNUAL CONFERENCE May 4, 2018 DIETARY SUPPLEMENTS RETAILER ISSUES AND LIABILITY Jean Frydman, Partner, Chair FDA Practice Fox Rothschild, LLP FDA Concern is Safety Only DHSEA Act of 1994 Know what
More informationG O L D E N S E A L R O O T P O W D E R
T H E A M E R I C A N H E R B A L P R O D U C T S A S S O C I A T I O N S GUIDANCE CA PROPOSITION 65: G O L D E N S E A L R O O T P O W D E R AUGUST 2016 This document is the property of the American Herbal
More informationNutrition Labeling Laws for Food and Supplements Timeline
Federal Food, Drug, and Cosmetic Act (FDCA) Pure Food and Drug Act (PFDA) Wheeler-Lea Act st Multivitamin 920 938 Food Additives Amendment 906 st Dietary 934 958 Supplements Year Description Reference
More informationSTATEMENT OF JOSHUA M. SHARFSTEIN, M.D. PRINCIPAL DEPUTY COMMISSIONER U.S. FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES
DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring, MD 20993 STATEMENT OF JOSHUA M. SHARFSTEIN, M.D. PRINCIPAL DEPUTY COMMISSIONER U.S. FOOD AND DRUG
More informationParticular challenges of evaluation of herbal combination products
Particular challenges of evaluation of herbal combination products Reinhard Länger, PhD, Assoc. Prof. Austrian Medicines and Medical Devices Agency (AGES MEA/BASG) Dept. for Herbal, Homeopathic & Veterinary
More informationSilliker Nutrient and Health Claims U.S. and Canadian Regulatory Guide
Silliker Nutrient and U.S. and Canadian Regulatory Guide Technical Content by Food Consulting Company 2013 Edition With over 40 years of experience and part of the Mérieux Alliance group of companies,
More informationScientific Exchange: What Every Compliance Officer Should Consider
Scientific Exchange: What Every Compliance Officer Should Consider Saul B. Helman, M.D October 21, 2015 The Sixteenth Pharmaceutical Compliance Congress and Best Practices Forum DISPUTES & INVESTIGATIONS
More informationPublic Hearing Before U.S. Food and Drug Administration
Substances in Food and Labeling; Regulatory Framework for Foods that Companies are Marketing as Functional Foods Public Hearing Before U.S. Food and Drug Administration Ilene Ringel Heller Senior Staff
More informationMark M. Yacura. Partner
Mark M. Yacura Partner Mark M. Yacura focuses his practice primarily on FDA legal and regulatory matters. He has practiced in this area for more than 30 years. He represents his clients before administrative
More information5.I.1. GENERAL PRACTITIONER ANNOUNCEMENT OF CREDENTIALS IN NON-SPECIALTY INTEREST AREAS
Report of the Council on Ethics, Bylaws and Judicial Affairs on Advisory Opinion 5.I.1. GENERAL PRACTITIONER ANNOUNCEMENT OF CREDENTIALS IN NON-SPECIALTY INTEREST AREAS Ethical Advertising under ADA Code:
More informationThe Food for Specific Groups (Information and Compositional Requirements) (England) Regulations 2016
INFORMATION NOTE INTENDED FOR KNOWLEDGE HUB The Food for Specific Groups (Information and Compositional Requirements) (England) Regulations 2016 This note is to alert you to the fact that the English Statutory
More informationTGA: the current regulatory reform agenda
TGA: the current regulatory reform agenda ASMI 2012 Conference: 13 November 2012 Future proofing the consumer healthcare industry Dr John Skerritt, National Manager The Therapeutic Goods Administration
More informationImprovising Claims. - Dr. R. B. Smarta
Improvising Claims - Dr. R. B. Smarta Labelling is usually perceived as an important aspect in informing the consumers about the contents of food/nutraceuticals in the finished products. Claims allow the
More informationNutritional Criteria for Labeling Claims
Nutritional Criteria for Labeling Claims Barbara O. Schneeman, Ph.D. Office of Nutrition, Labeling and Dietary Supplements Center for Food Safety and Applied Nutrition/ Food and Drug Administration Department
More informationMitch Zeller, Director, Center for Tobacco Products, FDA September 19, 2013 Kansas Public Health Association
Regulatory Public Laws Compliance & Education Policies Science & Enforcement & Communications The FDA Center for Tobacco Products (CTP): Its Role in Reducing Tobacco Use Mitch Zeller, Director, Center
More informationWeb Meeting Sep 20, Presented by: Kimberly Belsky, DIA AdPromo WG Chair DIA, Inc. All Rights Reserved.
OPDP Warning Letter Posted Sep 2017 FDA Draft Guidance Medical Product Communications That Are Consistent With the FDA-Required Labeling Q&A s (Issued January 2017) Web Meeting Sep 20, 2017 Presented by:
More informationOverview of IOM Studies Relevant to Food and Beverage Marketing to U.S. Children and Youth
Overview of IOM Studies Relevant to Food and Beverage Marketing to U.S. Children and Youth DHHS & FTC Workshop Marketing, Self-Regulation, and Childhood Obesity July 15, 2005 Vivica Kraak, M.S., R.D. Institute
More informationFood and Drug Law. Fall Syllabus. Professor Jesson. Hamline University School of Law
Food and Drug Law Fall 2009 Syllabus Professor Jesson Hamline University School of Law General course Information: Course: Food and Drug Law Credits: 2 Classroom: Law 103 Time: Thursdays, 4-5:50 p.m. Professor:
More informationAccess to clinical trial information and the stockpiling of Tamiflu. Department of Health
MEMORANDUM FOR THE COMMITTEE OF PUBLIC ACCOUNTS HC 125 SESSION 2013-14 21 MAY 2013 Department of Health Access to clinical trial information and the stockpiling of Tamiflu 4 Summary Access to clinical
More informationAligning a Product s Marketing, Regulatory and IP Plans
Aligning a Product s Marketing, Regulatory and IP Plans CLIENT ALERT September 8, 2017 Raymond A. Miller millerra@pepperlaw.com Barry H. Boise boiseb@pepperlaw.com Jessica A. Rickabaugh rickabaughj@pepperlaw.com
More informationPROBIOTICS: WHO S WHO AND WHAT S WHAT IN THE GUT PROBIOTICS: WHAT ARE THEY, AND HOW DO THEY WORK? Karen Jensen, (Retired ND)
PROBIOTICS: WHO S WHO AND WHAT S WHAT IN THE GUT Karen Jensen, (Retired ND) Today many people are aware of the benefits of maintaining a healthy gut. As a result, probiotic use is becoming ever more popular.
More informationStudy Endpoint Considerations: Final PRO Guidance and Beyond
Study Endpoint Considerations: Final PRO Guidance and Beyond Laurie Burke Associate Director for Study Endpoints and Labeling OND/CDER/FDA Presented at: FIRST ANNUAL PATIENT REPORTED OUTCOMES (PRO) CONSORTIUM
More informationRe: National Bioengineered Food Disclosure Standard; Proposed Rule; Request for Comments, 83 Fed. Reg (May 4, 2018), Docket No.
VIA ELECTRONIC SUBMISSION July 3, 2018 Dockets Management Staff (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: National Bioengineered Food Disclosure Standard;
More informationNaloxone Expanded Access: OTC status Considerations for a Nonprescription Drug Development Program
Naloxone Expanded Access: OTC status Considerations for a Nonprescription Drug Development Program Andrea Leonard-Segal, M.D., M.S. Director, Division of Nonprescription Clinical Evaluation 1 Contents
More informationEffect of the First Amendment on Off-Label Marketing
www.bipc.com Effect of the First Amendment on Off-Label Marketing Linda Pissott Reig Shareholder 550 Broad Street, Suite 810, Newark, NJ 07102-4582 973 424 5618 linda.reig@bipc.com ABA Section of Litigation
More informationCrowe Healthcare Webinar Series
Crowe Healthcare Webinar Series Healthcare Providers Ongoing Challenges With Controlled Substances Presented by: Scott Gerard, Healthcare Risk Consulting Partner Eric Jolly, Healthcare Risk Vice President
More informationRE: Permits under the Arizona Pharmacy Act should not be required for dietary supplements
Board Members Arizona State Board of Pharmacy 1616 W. Adams St., Suite 120 Phoenix, AZ 85007 c/o Kam Gandhi, PharmD Executive Director Arizona State Board of Pharmacy Via email: kgandhi@azpharmacy.gov
More informationUNITED STATES OF AMERICA FEDERAL TRADE COMMISSION. William E. Kovacic J. Thomas Rosch Edith Ramirez Julie Brill COMPLAINT
0923087 UNITED STATES OF AMERICA FEDERAL TRADE COMMISSION COMMISSIONERS: Jon Leibowitz, Chairman William E. Kovacic J. Thomas Rosch Edith Ramirez Julie Brill ) In the Matter of ) ) DOCKET NO. NESTLÉ HEALTHCARE
More informationRegulation of Dietary Supplements
(name redacted) Analyst in Health Policy December 16, 2014 Congressional Research Service 7-... www.crs.gov R43062 Summary Many Americans take dietary supplements (e.g., vitamins, herbs, sports nutrition
More informationConsistent with Labeling Final Guidance: Implications for Devices
Consistent with Labeling Final Guidance: Implications for Devices Vernessa Pollard, Partner, McDermott Will & Emery Cassie Scherer, Principal Legal Counsel, Medtronic Jeffrey Shapiro, Director, Hyman,
More informationDetermining Whether A Dietary Supplement Study Requires an Investigational New Drug (IND)
Determining Whether A Dietary Supplement Study Requires an Investigational New Drug (IND) 02/02/16 description Does a study that claims their dietary supplement promotes healthy joints and cartilage or
More informationCED GUIDELINES TO INTERPRET AND IMPLEMENT COUNCIL DIRECTIVE 2011/84/EU ON TOOTH WHITENING PRODUCTS
CED GUIDELINES TO INTERPRET AND IMPLEMENT COUNCIL DIRECTIVE 2011/84/EU ON TOOTH WHITENING PRODUCTS I INTRODUCTION This document provides guidance for interpreting and implementing the Council Directive
More informationAdvertising by Orthopaedic Surgeons
Opinion on Ethics and Professionalism Advertising by Orthopaedic Surgeons An AAOS Opinion on Ethics and Professionalism is an official AAOS statement dealing with an ethical issue, which offers aspirational
More informationGAO FOOD SAFETY. Improvements Needed in Overseeing the Safety of Dietary Supplements and Functional Foods. Report to Congressional Committees
GAO United States General Accounting Office Report to Congressional Committees July 2000 FOOD SAFETY Improvements Needed in Overseeing the Safety of Dietary Supplements and Functional Foods GAO/RCED-00-156
More informationmarket safety evaluations required of other new food ingredients.
Dietary Supplements: regulation and research Diane F. Birt Distinguished Professor Food Science and Human Nutrition, Iowa State University Students will: Objectives: Understand supplement definitions Be
More informationComments in Response to the April 18 Workshop: Now Hear This: Competition, Innovation, and Consumer Protection Issues in Hearing Health Care
Federal Trade Commission Office of the Secretary 600 Pennsylvania Avenue Washington, DC 20580 RE: Comments in Response to the April 18 Workshop: Now Hear This: Competition, Innovation, and Consumer Protection
More informationAn Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis. February 2018
An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis February 2018 I m here today to provide 1 2 3 Context for the Government of Canada s plan to legalize,
More informationAre You Considering Using CAM?
Are You Considering Using CAM? Decisions about your health care are important including decisions about whether to use complementary and alternative medicine (CAM). The National Center for Complementary
More informationPARKINSON S AND HERBAL SUPPLEMENTS ERICA MARINI, PHARMD UNIVERSITY OF UTAH NEUROLOGY
PARKINSON S AND HERBAL SUPPLEMENTS ERICA MARINI, PHARMD UNIVERSITY OF UTAH NEUROLOGY OBJECTIVES What is the difference between herbal supplements, over the counter medicines, and prescription medicines?
More informationCommon Criteria for Cosmetic Claims
Common Criteria for Cosmetic Claims Job done or the opening of Pandora s Box? Dr Chris Flower Director-General Cosmetic, Toiletry and Perfumery Association www.ctpa.org.uk Presentation summary: CAP/BCAP
More informationOUR COMMITMENT OPEN DIALOGUE & DEBATE COMMITMENT TO EDUCATION
Everyday we make choices and take actions that ensure the scientific-basis and quality of Nature Made vitamins and supplements. As a vitamin and supplement company, for Nature Made transparency means:
More informationSTATEMENT OF THE AMERICAN DENTAL ASSOCIATION ON REGULATION BY STATE BOARDS OF DENTISTRY OF MISLEADING DENTAL SPECIALTY CLAIMS.
STATEMENT OF THE AMERICAN DENTAL ASSOCIATION ON REGULATION BY STATE BOARDS OF DENTISTRY OF MISLEADING DENTAL SPECIALTY CLAIMS August 10, 2018 From time to time, general dentists who are not adequately
More informationProbiotics. Wide spectrum of important health benefits
Probiotics Part 1: What Are Probiotics? Probiotics are live microorganisms that inhabit the respiratory and gastrointestinal tracts and the skin. They are often referred to as friendly bacteria as they
More informationModified Risk Tobacco Product Applications A Succinct ENDS Industry Perspective
Modified Risk Tobacco Product Applications A Succinct ENDS Industry Perspective Patricia I. Kovacevic General Counsel, Chief Compliance Officer Presentation to the Food and Drug Law Institute Tobacco Conference,
More informationNestle Infant Nutrition 10/31/14
U.S. Food and Drug Administration Protecting and Promoting Your Health Nestle Infant Nutrition 10/31/14 OCT 31, 2014 Department of Health and Human Services Public Health Service Food and Drug Administration
More informationRegulatory Systems of Health Claims in Japan. June, 2011 Consumer Affairs Agency Food Labelling Division
Regulatory Systems of Health Claims in Japan June, 2011 Consumer Affairs Agency Food Labelling Division Mission of the Consumer Affairs Agency (CAA) Article 2 of the Consumer Basic Act sets out the state
More informationGSCI 2202 FOOD FOR HEALTH. Eat to compete: Dietary Supplements
GSCI 2202 FOOD FOR HEALTH Eat to compete: Dietary Supplements Dietary supplements on the market are: NOT regulated Could contain illegal substances Could be costly Could be harmful Current laws on dietary
More informationAn update on the regulatory framework for labelling across the EU Dr David Jukes Department of Food and Nutritional Sciences University of Reading
Sugar, salt and fat: strategies to reduce consumption Nutritional labelling: standards, guides and regulations An update on the regulatory framework for labelling across the EU Dr David Jukes Department
More information(Cochineal Extract and Carmine: Declaration by Name on the Label of All Foods and Cosmetic Products That Contain These Color Additives)
ก ก 2553 ก : ก (Cochineal Extract and Carmine: Declaration by Name on the Label of All Foods and Cosmetic Products That Contain These Color Additives) : ก ก ก : ก ก ก : 2552 : 2552 1 ก 5 ก : ก (Cochineal
More informationAn Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis
An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis I m here today to provide 1 2 3 Context for the Government of Canada s plan to legalize, regulate
More informationFang-Chi Chang (M.D.,Ph.D.) Center for Drug Evaluation, Taiwan
Fang-Chi Chang (M.D.,Ph.D.) Center for Drug Evaluation, Taiwan Outline Herbal Medicines in the U.S. Herbal Medicines in EU Herbal Medicines in Australia Herbal Medicines in Asia & Taiwan Regulatory Strategy
More informationChallenges and solutions in making evidence-based national vaccination policies and recommendations
Challenges and solutions in making evidence-based national vaccination policies and recommendations Philippe Duclos, WHO 15th ADVAC, Les Pensières, Veyrier du Lac, May 19, 2014 Developing evidence-based
More informationCIAA COMMENTS ON DG SANCO DISCUSSION PAPER ON NUTRITIONAL AND FUNCTIONAL CLAIMS
CIAA COMMENTS ON DG SANCO DISCUSSION PAPER ON NUTRITIONAL AND FUNCTIONAL CLAIMS SANCO/1341/2001 MIN/144/01E Final CIAA 2 CIAA KEY PRINCIPLES ON CLAIMS The Food and Drink industry has responded to government
More informationAgency Information Collection Activities; Submission for Office of Management and Budget
This document is scheduled to be published in the Federal Register on 01/28/2016 and available online at http://federalregister.gov/a/2016-01690, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN
More informationPresentation: Philip G. Hampton, II Haynes and Boone, LLP (202) September 14, 2017
Presentation: Philip G. Hampton, II Haynes and Boone, LLP (202) 654-4533 September 14, 2017 What is a Trademark? A trademark is any word, product name, symbol or device that identifies the goods or services
More informationDocuments Regarding Drug Abuse Assessments
Overview of the FDA Guidance Documents Regarding Drug Abuse Assessments ABUSE DETERRENT FORMULATION SCIENCE MEETING DISCUSSION OF THE FDA DRAFT GUIDANCE FOR INDUSTRY: ABUSE DETERRENT OPIOIDS EVALUATION
More informationGUIDELINES: PEER REVIEW TRAINING BOD G [Amended BOD ; BOD ; BOD ; Initial BOD ] [Guideline]
GUIDELINES: PEER REVIEW TRAINING BOD G03-05-15-40 [Amended BOD 03-04-17-41; BOD 03-01-14-50; BOD 03-99-15-48; Initial BOD 06-97-03-06] [Guideline] I. Purpose Guidelines: Peer Review Training provide direction
More informationThe Marketing of a Food Ingredient Understanding a System that has Worked for 105 Years
The Marketing of a Food Ingredient Understanding a System that has Worked for 105 Years Gary L. Yingling Food Policy Impact December 2011 Copyright 2011 by K&L Gates LLP. All rights reserved. Brief Historical
More informationThe science behind labeling issues and health claims a European perspective
2005 CSL/JIFSAN Joint Symposium on Food Safety and Nutrition: Bioactive Food Components The science behind labeling issues and health claims a European perspective Dr Michele Kellerhals Scientific and
More informationFDA issues long-awaited final guidance on when a device modification requires a new 510(k)
FDA issues long-awaited final guidance on when a device modification requires a new 510(k) November 2, 2017 Six years after its first attempt to update its 20-year-old guidelines for when modifications
More informationProtein Quality and Labeling: Defending Attacks from Regulators, Attorneys and Competitors
Protein Quality and Labeling: Defending Attacks from Regulators, Attorneys and Competitors May 23, 2018 Justin J. Prochnow prochnowjj@gtlaw.com (303) 572-6562 GREENBERG TRAURIG, LLP ATTORNEYS AT LAW WWW.GTLAW.COM
More informationUpdate from the European Commission s Working Group meeting on health claims, 31 March 2015
Update from the European Commission s Working Group meeting on health claims, 31 March 2015 There was discussion on a generic descriptor application and a number of health claims, including those mentioned
More informationNew York Attorney General Targets Supplements at Major Retailers
New York Attorney General Targets Supplements at Major Retailers By ANAHAD O'CONNOR NY Times FEBRUARY 3, 2015 12:00 AM A Target in East Harlem. It and three other retailers GNC, Walgreens and Walmart were
More informationREGULATIONS IN FOOD INGREDIENTS
REGULATIONS IN FOOD INGREDIENTS Prepared by: CPL Business Consultants The Manor House, Howbery Park, Wallingford, Oxfordshire, OX10 8BA Tel: +44 1491 822 844, info@cplconsult.com, www.cplconsult.com Catherine
More informationdietary supplements are not subject to the premarket safety evaluations required of other new food ingredients.
Dietary Supplements: regulation and research Diane F. Birt Distinguished Professor Food Science and Human Nutrition, Iowa State University Objectives: Students will: Understand supplement definitions Be
More informationELEVEN REASONS WHY S IS BAD PUBLIC POLICY. Clinton Admin. FY00 budget request for FDA tobacco regulation was $34 million.
ELEVEN REASONS WHY S. 2461 IS BAD PUBLIC POLICY 1. Creates New Bureaucracy. Clinton Admin. FY00 budget request for FDA tobacco regulation was $34 million. S.2461 includes a tax increase of $300 million
More informationContent. Research Rationale. Perceptions, Attitudes and Understanding of Health Claims on Milk for Children among the Indonesian Mothers
Perceptions, Attitudes and Understanding of Health Claims on Milk for Children among the Indonesian Mothers Ms Karin Tan PhD Candidate Newcastle University (Singapore) Why Who & How Results Next Steps
More information